Atlas Trials

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

Clinical trial NCT07605052 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07605052
Sponsor
Novo Nordisk A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
OverweightObesity
Start date
2026-05-20
Primary completion
2026-09-03
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.